Regulation - NPS Pharmaceuticals


Current filters:

NPS Pharmaceuticals

Popular Filters

Orphan designation for NPS Pharma’s Natpara in Europe


The European Commission has granted orphan drug designation to US biotech firm NPS Pharmaceuticals Natpara…

BiotechnologyNatparaNPS PharmaceuticalsRare diseasesRegulation

Unanimous FDA advisory panel backing for NPS Pharma's Gattex


The US Food and Drug Administration's Gastrointestinal Drugs Advisory Committee yesterday voted unanimously…

Gastro-intestinalsGattexNorth AmericaNPS PharmaceuticalsPharmaceuticalRegulationteduglutide

FDA posts briefing papers for review of NPS Pharma's Gattex for SBS


The USA Food and Drug Administration has posted briefing materials for the October 16 Gastrointestinal…

Gastro-intestinalsGattexNorth AmericaNPS PharmaceuticalsPharmaceuticalRegulation

Takeda's Revestive gets EU clearance for short bowel syndrome


Japan's largest drugmaker Takeda Pharmaceutical (TSE: 4502) and partner NPS Pharmaceuticals (Nasdaq:…

EuropeGastro-intestinalsNPS PharmaceuticalsPharmaceuticalRegulationRevestiveTakeda Pharmaceuticals

Back to top